C
CSPC Pharmaceutical Group Ltd
HKEX:1093
CSPC Pharmaceutical Group Ltd
HKEX:1093
Price:
9.27
HKD
-0.22%
Market Closed
Market Cap:
HK$106.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
CN |
|
Alamo Group Inc
NYSE:ALG
|
US |
|
Jiangsu Hengli Hydraulic Co Ltd
SSE:601100
|
CN |
|
Amlogic Shanghai Co Ltd
SSE:688099
|
CN |
|
Qingdao Port International Co Ltd
SSE:601298
|
CN |
|
Beijing Jingwei Hirain Technologies Co Inc
SSE:688326
|
CN |
|
P
|
PetroVietnam Fertilizer and Chemicals Corp
VN:DPM
|
VN |
|
G
|
Guangzhou LBP Medicine Science & Technology Co Ltd
SSE:688393
|
CN |
|
Bobst Group SA
SIX:BOBNN
|
CH |
|
WuXi AppTec Co Ltd
SSE:603259
|
CN |
|
China Hainan Rubber Industry Group Co Ltd
SSE:601118
|
CN |
|
Burnpur Cement Ltd
NSE:BURNPUR
|
IN |
|
F
|
Firefly Aerospace Inc
NASDAQ:FLY
|
US |
|
Superdry PLC
LSE:SDRY
|
UK |
|
Maruti Suzuki India Ltd
NSE:MARUTI
|
IN |
|
Sulabh Engineers and Services Ltd
BSE:508969
|
IN |
Multiples-Based Value
The Multiples-Based Value of one CSPC Pharmaceutical Group Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 9.27 HKD, CSPC Pharmaceutical Group Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
CSPC Pharmaceutical Group Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
CSPC Pharmaceutical Group Ltd Competitors
CSPC Pharmaceutical Group Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
C
|
CSPC Pharmaceutical Group Ltd
HKEX:1093
|
107B HKD | 3.3 | 22.3 | 16.9 | 16.9 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD | 12.9 | 40.6 | 27.4 | 29.3 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD | 6.2 | 21.8 | 15.1 | 18.6 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
228B GBP | 5.2 | 29.9 | 16.5 | 23.3 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD | 4.5 | 16 | 9.9 | 12.1 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.6B CHF | 5.3 | 21.2 | 13.1 | 16.9 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 10 | 7.5 | 8.7 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 20.3 | 7.8 | 10.4 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.2B USD | 2.5 | 17.1 | 7.2 | 8.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
